high priority NIH/NIAID has on developing a vaccine and treatment would help bring the content
together.

We know this is likely not possible, with the very short notice and your even more tremendously busy
schedule around all of this. But it’s worth the ask.

Please let me know if you think either of these is possible. And Patty, sorry for butchering your email
address earlier.

Best,

Donna

Donna M. Jacobsen

Executive Director/President

International Antiviral (formerly AIDS) Society-USA
Executice Manager, CROI

131 Steuart St, Ste 500

San Francisco, CA 94105

415-544-9400

httos://‘www.iasusa.or

GOB
VN

ACE M i About lAS-USA: Established in 1992, the IAS—USA is a not-for-profit, professional education
organization. The mission of the IAS-USA is to improve the prevention, treatment, care, and quality of life
for people with or at risk of HIV, hepatitis C virus, or other viral infections through high-quality, relevant,
balanced, and needs-oriented education and information for practitioners who are actively involved in
medical care. The organization's educational activities are particularly intended to bridge clinical research
and patient care.

 

Confidentiality Notice: This e-mail and its attachments may contain privileged and confidential
information intended solely for the use of the IAS-USA and the recipient(s) named above. If you are not
the intended recipient, or the employee or agent responsible for delivering this message to the intended
recipients, you are hereby notified that any review, dissemination, distribution, printing, or copying of this
e-mail message and/or any attachments is strictly prohibited. If you have received this transmission in
error, please notify the sender immediately and permanently delete this e-mail and any attachments.

From: Fauci, Anthony (NIH/NIAID) [EJEY )

Sent: Thursday, February 20, 2020 7:12 AM

NIH-001686
